Fetal growth restriction, or a fetus not reaching its full growth potential in utero, is a common obstetrical complication. Our research aims to improve how we diagnose and manage pregnancies affected by fetal growth restriction.
Funded by: BC Children’s Hospital Research Institute and Michael Smith Health Research BC
Read some of our past publications on this topic!
Liauw J, Groom K, Ganzevoort W, et al. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis. Syst Rev 10, 305 (2021). https://doi.org/10.1186/s13643-021-01849-5
Hutcheon JA, Liauw J. Should Fetal Growth Charts Be References or Standards? Epidemiology. 2021 Jan;32(1):14-17. doi: 10.1097/EDE.0000000000001275.
Liauw J, Jacobsen GW, Larose TL, Hutcheon JA. Short interpregnancy interval and poor fetal growth: Evaluating the role of pregnancy intention. Paediatr Perinat Epidemiol. 2019 Jan;33(1):O73-O85.